TEGNA INC

TGNA

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
TGNA
CIK0000039899
SIC4833
SectorTransportation, Communications, Electric, Gas, And Sanitary Services
Industry CategoryCommunication
Industry GroupRadio & Tv Broadcasters

Contact

Address8350 BROAD STREET, SUITE 2000, TYSONS, VA, 22102-5151
Website tegna.com
Phone7038736600
CEODavid T. Lougee
Employees6,300

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$2.88 billion
Pre-Tax Income$442.86 million
Net Income$343.89 million
Net Income to Common$344.38 million
EPS$2.11
View All
Balance Sheet
Cash$232.78 million
Assets$6.81 billion
Liabilities$3.69 billion
Common Equity$3.12 billion
Liabilities & Equity$6.81 billion
View All
Cash Flow Statement
Calculations
NOPAT$465.16 million
EBITDA$624.52 million
Price to Earnings$9.16
Price to Book$1.01
ROE11.45%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Why Is TEGNA (TGNA) Down 3.2% Since Last Earnings Report?

TEGNA (TGNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Article Link

New Year's at the Needle Returns: The West Coast Window to the World

The Space Needle is proud to announce the return of New Year's at the Needle; the premier New Year's Eve show broadcast across four markets down the coast to viewers in Seattle, Spokane, Portland and San Diego. Alaska Airlines will return as the presenting sponsor of Seattle's iconic pyrotechnic and light spectacular to welcome 2026. Viewers along the coast will tune in to watch hundreds of drones take to the sky, leading up to the largest structurally launched firework show in North America, br

Article Link

3 Unpopular Stocks We Think Twice About

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Article Link

Trump Trade: White House pauses EO preempting state laws on AI

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential AI STATE

Article Link

Novo's GLP-1 fails Alzheimer's trial goals, Tegna stock falls

Yahoo Finance anchor Julie Hyman tracks Monday's top moving stocks and biggest market stories in this Market Minute. Bitcoin (BTC-USD) is down about 30% from its peak, trading around $87,000. Shares of broadcast company Tegna (TGNA) are falling after President Trump said he was against the Federal Communications Commission (FCC) lifting its cap on local TV station ownership. Novo Nordisk (NVO) stock is under pressure after the company's GLP-1 failed its late-stage trial goals for treating Alzheimer's. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Article Link